Sign in
CompletedNo phase

Artificial Intelligence, and E-Health Literacy in Fibromyalgia

Key facts

Who runs it
Gulseren Demir Karakilic
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
212 people enrolled
Started
16 Dec 2024
Ended
30 May 2025
Type of study
Observational, 2 groups
Treatments tested
  • Observation only
Record updated
13 June 2025

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Age between 18 and 50 years
  • Diagnosis of Fibromyalgia Syndrome according to 2016 American College of Rheumatology criteria (for patient group)
  • Adequate cognitive function
  • Literacy
  • Willingness to participate and provide informed consent
  • For control group: Healthy individuals matched by age and sex, with no reported health issues

Who cannot take part

  • Cognitive impairment preventing questionnaire completion
  • Presence of severe comorbidities or neurological/psychiatric disorders that may affect participation
  • Illiteracy
  • Refusal or inability to provide informed consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This cross-sectional observational study aimed to assess electronic health literacy and artificial intelligence literacy among individuals diagnosed with fibromyalgia syndrome, with particular focus on artificial intelligence literacy. Although general health literacy has been investigated in this patient population, digital and artificial intelligence-related competencies have not been sufficiently studied. The research included 106 individuals diagnosed with fibromyalgia syndrome and 106 age- and sex-matched healthy volunteers, recruited between December 2024 and May 2025. All participants completed a series of standardized questionnaires, including the Revised Fibromyalgia Impact Questionnaire, the Beck Depression Inventory, the Beck Anxiety Inventory, the Electronic Health Literacy Scale, and the Artificial Intelligence Literacy Scale. The study explored demographic, clinical, and psychological factors associated with digital and artificial intelligence literacy levels among both patient and control groups.

The 2 groups in the trial

  • the patient group

    Patients aged 18 to 50 who attended the Physical Medicine and Rehabilitation outpatient clinic at Bozok University Faculty of Medicine, met the 2016 American College of Rheumatology fibromyalgia diagnostic criteria, demonstrated adequate cognitive function, were literate, and consented to participate were enrolled as the patient group

    Treatment: Observation only

  • The control group

    The control group consisted of healthy volunteers matched to the patient group in terms of age and sex, aged 18-50 years, with intact cognitive function and literacy skills, no reported health issues, and who willingly consented to participate in the study

    Treatment: Observation only

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Investigation on Artificial Intelligence Literacy and E-Health Literacy of Patients With Fibromyalgia Syndrome
Publications
Record updated
13 June 2025